Support PenkeLexicon Pharmaceuticals Inc - Trending symbols
Latest News of Lexicon Pharmaceuticals Inc
| Date | Title | Read |
|---|---|---|
| 2025-09-22 22:30 | Lexicon reports FDA's decision to extend review period for Zynquista | Read |
| 2025-09-22 22:00 | Lexicon Pharmaceuticals Announces Update on Submission of Additional Data to U.S. FDA Supporting the Benefit-Risk Profile of Zynquista® in Type 1 Diabetes | Read |
Notifications
| Type | Notification | Date |
|---|---|---|
| RSI Overbought | Overbought RSI (Relative Strength Index) | 2025-10-10 |
Trends
| 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Income before Tax | -53,429 | -11,382 | -64,811 | 31,045 | -33,766 | 8,471 | -25,295 | 28,547 | 3,252 | |
| Net Income | -53,429 | -11,382 | -64,811 | 31,045 | -33,766 | 8,471 | -25,295 | 28,547 | 3,252 | |
| EBIT | -51,218 | -9,031 | -60,249 | 30,341 | -29,908 | 4,053 | -25,855 | 31,425 | 5,570 | |
| EBITDA | -51,079 | -9,044 | -60,123 | 30,340 | -29,783 | 4,104 | -25,679 | 31,425 | 5,746 | |
| Operating Income | -55,354 | -8,339 | -63,693 | 30,956 | -32,737 | 7,058 | -25,679 | 29,415 | 3,736 | |
| Net Income from Continuing Operations | -53,429 | -11,382 | -64,811 | 31,045 | -33,766 | 8,471 | -25,295 | 28,547 | 3,252 | |
| Interest Expense | 4,948 | -2,737 | 2,211 | 2,351 | 4,562 | -704 | 3,858 | -5,693 | -1,835 | |
| Net Debt | 9,750 | 60,309 | 70,059 | -3,414 | 66,645 | -24,904 | 41,741 | -62,573 | -20,832 | |
| Net Interest Income | -664 | -230 | -894 | -2,125 | -3,019 | -45 | -3,064 | 4,989 | 1,925 | |
| Total Other Income Expense Net | -664 | -230 | -894 | -613 | -1,507 | -1,557 | -3,064 | 4,989 | 1,925 | |
| Total Stockholder Equity | -1,589,720 | -31,934 | -1,621,654 | -44,904 | -1,666,558 | -50,525 | -1,717,083 | 1,810,193 | 93,110 | |
| Liabilities and Stockholders Equity | -1,512,545 | -34,439 | -1,546,984 | 10,789 | -1,536,195 | -43,919 | -1,580,114 | 1,809,543 | 229,429 | |
| Accumulated Other Comprehensive Income | -428 | 265 | -163 | 63 | -100 | -13 | -113 | 144 | 31 | |
| Other Stockholders Equity | 1,603,837 | 2,832 | 1,606,669 | 96,877 | 1,703,546 | -1,703,307 | 239 | -266 | -27 | |
| Income Tax Expense | 96 | 484 | 580 | -288 | 292 | -76 | 216 | -1,245 | -1,029 | |
| Long-term Assets Other | 1,231 | 1,774 | 3,005 | -335 | 2,670 | -199 | 2,471 | -22,880 | -20,409 |
Comments
How you think about this?